HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
Marks KM, Kang M, Umbleja T, Cox A, Vigil KJ, Ta NT, Omoz-Oarhe A, Perazzo H, Kosgei J, Hatlen T, Price J, Katsidzira L, Supparatpinyo K, Knowles K, Alston-Smith BL, Rathod P, Sherman KE; ACTG 5379 (BEe-HIVe) Study Team.
Marks KM, et al.
JAMA. 2025 Jan 28;333(4):295-306. doi: 10.1001/jama.2024.24490.
JAMA. 2025.
PMID: 39616603
Free PMC article.
Clinical Trial.
IMPORTANCE: Nonresponse to hepatitis B vaccine is common among people with HIV, resulting in vulnerability to infection with hepatitis B virus (HBV). ...MAIN OUTCOMES AND MEASURES: The primary outcome was a seroprotection response to hepatitis B vaccine (defi …
IMPORTANCE: Nonresponse to hepatitis B vaccine is common among people with HIV, resulting in vulnerability to infection with hepatiti …